Delivery Order SPE2DB22D2214-SPE2DB26FS2NA
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units, with a ceiling value of $9,366.47. This competitive, firm fixed-price delivery order is expected to be completed by August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $6,283.59 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) on August 6, 2025, with ultimate completion scheduled for August 7, 2025. This non-competitive delivery order utilizes firm fixed price terms and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $18,978.90. This non-set-aside competitive award is scheduled for completion by August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under the company's...
- The Defense Logistics Agency awarded a $3,284.65 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Eliquis 5 mg tablets (60-count). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 15, 2025. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $5,084.04 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Eliquis 5 mg tablets in a 60-count package. This competitively awarded, non-set-aside contract is scheduled for completion by July 25, 2025, with performance to be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $15,748.58 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $2,948.40 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count package) on September 8, 2025, with completion scheduled for September 9, 2025. This non-competitive delivery order utilizes firm fixed pricing and is performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, fulfills this order...
- The Defense Logistics Agency awarded a delivery order valued at $23,773.16 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 6, 2025, with an ultimate completion date of August 7, 2025. This non-competitive, firm fixed-price delivery order was issued under a competitive procurement process and represents a continuation of the vendor's ongoing pharmaceutical supply relationship with the federal government. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Eliquis 5 mg tablets (60-count package) with a firm fixed price ceiling value of $6,625.72 and an ultimate completion date of November 4, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a $14,034.53 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB26FS2NADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,199.39 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) on October 28, 2025, with completion scheduled for October 29, 2025. This non-competitive, firm fixed-price delivery order represents a continuation of pharmaceutical supply under the company's existing contract vehicle with the federal government. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical procurement needs, particularly for military and veteran healthcare systems operated by the Defense Health Agency. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor agreement enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. The current order for Eliquis, an anticoagulant medication, exemplifies the routine pharmaceutical deliveries that flow through this strategic contract vehicle, which encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 10/28/25 |